Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Lets help you get started on a healthier path today
Whilst these studies seem to be making strides in breast cancer treatment, one other preclinical study saw obese mice (fed a high-fat diet) injected subcutaneously with pancreatic cancer cells and treated with Semaglutide or Retatrutide (another GLP-1R agonist)
The compound was first studied in Phase 2 trials involving 338 participants over 48 weeks
In short: the ingredients have plausible mechanistic support (strongest for GHK-Cu)
US$ 25.07
US$ 22.71
US$ 28.14
US$ 29.25
